Cooper Companies (NASDAQ:COO) Director Walter Rosebrough, Jr. Buys 7,000 Shares of Stock

The Cooper Companies, Inc. (NASDAQ:COO) Director Walter Rosebrough, Jr. purchased 7,000 shares of Cooper Companies stock in a transaction that occurred on Friday, September 11th. The shares were bought at an average cost of $54.11 per share, for a total transaction of $378,770.00. Following the transaction, the director directly owned 17,000 shares of the company’s stock, valued at $919,870. This represents a 70.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Cooper Companies Price Performance

NASDAQ COO traded down $0.95 during midday trading on Tuesday, hitting $53.27. The company had a trading volume of 4,408,999 shares, compared to its average volume of 2,501,526. The company has a market capitalization of $10.13 billion, a PE ratio of 18.18, a P/E/G ratio of 2.19 and a beta of 0.82. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average price of $71.25 and a 200-day moving average price of $69.40. The Cooper Companies, Inc. has a twelve month low of $51.01 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.03. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The company’s revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, analysts anticipate that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies announced that its board has authorized a stock buyback program on Wednesday, September 9th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the medical device company to buy up to 22.7% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Institutional Investors Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently made changes to their positions in COO. Sequoia Financial Advisors LLC lifted its stake in Cooper Companies by 290.4% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 34,286 shares of the medical device company’s stock valued at $2,459,000 after purchasing an additional 25,504 shares during the last quarter. Tidal Investments LLC grew its stake in shares of Cooper Companies by 281.4% during the second quarter. Tidal Investments LLC now owns 82,903 shares of the medical device company’s stock worth $5,945,000 after buying an additional 61,165 shares during the last quarter. National Pension Service increased its holdings in shares of Cooper Companies by 9,314.0% during the second quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock worth $37,730,000 after buying an additional 520,560 shares in the last quarter. WINTON GROUP Ltd increased its holdings in shares of Cooper Companies by 379.0% during the second quarter. WINTON GROUP Ltd now owns 42,483 shares of the medical device company’s stock worth $3,046,000 after buying an additional 33,613 shares in the last quarter. Finally, Engineers Gate Manager LP lifted its stake in shares of Cooper Companies by 8,637.7% in the 2nd quarter. Engineers Gate Manager LP now owns 249,897 shares of the medical device company’s stock valued at $17,920,000 after acquiring an additional 247,037 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent analyst reports. Zacks Research lowered shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a report on Wednesday, May 27th. Weiss Ratings reiterated a “sell (d)” rating on shares of Cooper Companies in a research report on Friday, September 4th. Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Five equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $71.47.

About Cooper Companies

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.